Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Ранг среди акций #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Цена акции
$3.78
Последняя синхронизация: 2026-03-17
Рыночная капитализация
$276.54M
Изменение (1 день)
0.00%
Изменение (1 год)
45.53%
Страна
CA
Торговля NervGen Pharma Corp. (NGEN)

Категория

История цены акций NervGen Pharma Corp. (NGEN)
Наивысшая цена закрытия: $3.98 2026-03-01

Наименьшая цена закрытия: $1.12 2019-03-01
История цены акций NervGen Pharma Corp. с 2019 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.24 -10.01%
AU
$748.60 6.90%
CH